Prescribing Information
Indications
Important Safety Information
References
FAQ
Connect with a Rep
Visit Patient Site
Prescribing Info
Indications
Efficacy
DKd vs Kd study
Study design
Study results
Kd once weekly study
Study design
Study results
Kd vs Vd study
Study design
Study results
Results by patient type
KRd study
Study design
Study results
Results by patient type
Safety
Safety: DKd vs Kd Study
Safety: Kd once weekly
Safety: Kd vs Vd study
Safety: KRd vs Rd study
Dosing
DKd dosing
Kd once weekly dosing
Kd twice weekly dosing
KRd dosing
Administration and dose modifications
Mechanism of action
Multiple myeloma
Access & resources
Access & reimbursement
Resources
Frequently asked questions
FDA APPROVED
KYPROLIS
®
+Darzalex
®
(daratumumab)+dexamethasone
LEARN MORE
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm
